PHR — Pharmena SA Cashflow Statement
0.000.00%
- PLN37.87m
- PLN28.01m
- PLN0.27m
- 39
- 28
- 11
- 13
Annual cashflow statement for Pharmena SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.27 | -4.46 | -1.41 | -12 | -2.56 |
Depreciation | |||||
Non-Cash Items | 0.299 | 0.174 | 0.731 | 46.7 | -0.865 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.1 | 0.432 | 1.94 | -4.3 | 0.796 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.24 | -3.23 | 1.82 | 30.8 | -2.53 |
Capital Expenditures | -0.214 | -0.319 | -0.226 | -1.3 | -0.18 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.016 | 0.071 | 0.007 | 0.409 | -8.18 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.198 | -0.248 | -0.219 | -0.892 | -8.36 |
Financing Cash Flow Items | 0.925 | -1.07 | -0.812 | -0.859 | -0.015 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.12 | 3.21 | -1.47 | -9.22 | -9.54 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.674 | -0.259 | 0.132 | 20.7 | -20.4 |